# ROTATEQ Reexamination Study (V260-037)

> **NCT01074242** · — · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 3798 (actual)

## Conditions studied

- Gastroenteritis Rotavirus

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01074242
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 3798 (ACTUAL)
- **Last updated:** 2017-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01074242

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01074242, "ROTATEQ Reexamination Study (V260-037)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01074242. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*